National Association of Testing Authorities, Australia
Scope of Accreditation
Royal Prince Alfred Hospital Clinical Neuroscience Laboratories
Site
Royal Prince Alfred Hospital Clinical Neuroscience Laboratories
Accreditation No.
20911
Site No.
25131
Date of Accreditation
20 Feb 1990
Address
100 Mallett Street
Camperdown, NSW 2050
Australia
Contact
Assoc Prof Michael Buckland P: +61 (02) 93510741
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Royal Prince Alfred Hospital Clinical Neuroscience Laboratories
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Service | Product | Determinant |
---|---|---|
Anatomical pathology - Tissue pathology - Examination of biopsy material | Fresh tissue; Muscle; Nerve biopsy | In-vitro contraction test; Nerve conduction studies; Neuromuscular disorders; Review and reporting of biopsy material to identify or exclude morphological abnormalities; Structured reporting |
Anatomical pathology - Tissue pathology - Examination of biopsy materialAutopsy material received from Forensic institutes and hospitals. | Brain - Whole | Presence or absence of Creutzfeldt-Jacob disease |
Brain - Whole; Spinal cord | Review and reporting of material to identify neurological diseases | |
Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues; Frozen sections of fresh tissue | Detection of antigenic targets - Various |
Anatomical pathology - Tissue pathology - Skeletal muscle enzyme histochemistry | Frozen sections of skeletal muscle | Detection of muscle enzyme targets |
Molecular genetics - DNA extraction | Formalin-fixed paraffin-embedded (FFPE) tissues; Frozen tissue | DNA storage for future analyses; Purified PCR product; Sample assessment and identification; Viable DNA; Viable DNA for sequencing; Viable DNA for sequencing and other molecular assays |
Molecular genetics - DNA sequencing | Formalin-fixed paraffin-embedded (FFPE) tissues; Frozen tissue | DNA sequence analysis; Pyrosequencing; Sequenced DNA; Sequenced DNA utilising massively parallel sequencing technologies |
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Formalin-fixed paraffin-embedded (FFPE) tissues | Copy number variation (CNV); Glioma panel |
MGMT promoter methylation analysis | ||
H3f3A mutation analysis | ||
TERT promoter mutation analysis | ||
Isocitrate dehydrogenase IDH1 and IDH2 mutation analysis | ||
Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences; FASTQ files; RNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20911
Site No.
25131
Print date
26 Nov 2024
END OF SCOPE